Spelling suggestions: "subject:"HIV infections.in long"" "subject:"HIV infections.in hong""
1 |
Sexual network, partnership pattern and HIV risk of men having sex with men (MSM) in Hong Kong.January 2009 (has links)
Tam, Ka Po. / Thesis submitted in: September 2008. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2009. / Includes bibliographical references (leaves 151-161). / Abstracts in English and Chinese. / Abstract --- p.i / Acknowledgement --- p.vi / Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Human Immunodeficiency Virus --- p.1 / Chapter 1.2 --- Sexual Transmission of HIV --- p.3 / Chapter 1.3 --- HIV Prevalence in MSM Worldwide --- p.5 / Chapter 1.4 --- Risk Factors for Homosexual Men --- p.8 / Chapter 1.4.1 --- Individual Factors --- p.8 / Chapter 1.4.2 --- Societal Factors --- p.12 / Chapter 1.5 --- HIV Prevalence of MSM in Hong Kong --- p.17 / Chapter 2 --- Literature Review --- p.21 / Chapter 2.1 --- The Literature Search --- p.22 / Chapter 2.2 --- Results --- p.25 / Chapter 2.3 --- Reasons to Conduct Social Network Study --- p.26 / Chapter 2.4 --- Review on Methodologies --- p.29 / Chapter 2.4.1 --- Data Source --- p.29 / Chapter 2.4.2 --- Sampling Methods --- p.30 / Chapter 2.5 --- Review on Major Findings --- p.33 / Chapter 2.5.1 --- Individual Characteristics --- p.33 / Chapter 2.5.2 --- Partnerśة Characteristics --- p.34 / Chapter 2.5.3 --- Network Characteristics --- p.38 / Chapter 2.6 --- Critique --- p.40 / Chapter 2.7 --- Implication --- p.46 / Chapter 3 --- Methods --- p.49 / Chapter 3.1 --- Study Design --- p.49 / Chapter 3.1.1 --- Sampling --- p.50 / Chapter 3.1.2 --- Terminology --- p.51 / Chapter 3.2 --- Instruments --- p.56 / Chapter 3.2.1 --- Self-administered Questionnaire --- p.56 / Chapter 3.2.2 --- Demographics --- p.57 / Chapter 3.2.3 --- Setting of Infection --- p.57 / Chapter 3.2.4 --- Partnership Pattern --- p.59 / Chapter 3.2.5 --- Semi-structured Interviewing Guide --- p.61 / Chapter 3.2.6 --- Last Sexual Episode --- p.62 / Chapter 3.2.7 --- Sexual Role --- p.63 / Chapter 3.2.8 --- Partner Selection --- p.63 / Chapter 3.2.9 --- Bem Sex-Role Inventory --- p.64 / Chapter 3.3 --- Data Analysis --- p.66 / Chapter 3.4 --- Ethical Considerations --- p.70 / Chapter 4 --- Results --- p.74 / Chapter 4.1 --- Sampling --- p.74 / Chapter 4.2 --- Characteristics of Respondents --- p.75 / Chapter 4.2.1 --- Demographics --- p.75 / Chapter 4.2.2 --- Settings of Infection --- p.77 / Chapter 4.2.3 --- HIV Test --- p.79 / Chapter 4.3 --- Partnership Pattern --- p.82 / Chapter 4.3.1 --- Partner Types --- p.83 / Chapter 4.3.2 --- Location for Partner Sourcing --- p.84 / Chapter 4.3.3 --- Characteristics of Sex Partners --- p.86 / Chapter 4.3.4 --- Sexual Behavioural Pattern --- p.87 / Chapter 4.3.5 --- The Influence of Partner Types --- p.92 / Chapter 4.3.6 --- Last Sex with Lover(s) and/or Regular Partner(s) --- p.95 / Chapter 4.3.7 --- Sexual Role in Anal Intercourse --- p.98 / Chapter 4.4 --- Networking Pattern --- p.103 / Chapter 4.4.1 --- Individual Network --- p.104 / Chapter 4.4.2 --- Cluster Analysis (with 2-mode correspondence analysis) --- p.108 / Chapter 4.4.3 --- Social Network Analysis --- p.115 / Chapter 5 --- Discussion --- p.122 / Chapter 5.1 --- Possible Existence of 2 Sexual Networks in Hong Kong --- p.123 / Chapter 5.1.1 --- Network Configuration --- p.123 / Chapter 5.1.2 --- Network-related Behaviours --- p.128 / Chapter 5.2 --- Impact of Partnership Pattern on HIV Transmission --- p.129 / Chapter 5.3 --- The Importance of Sexual Role --- p.135 / Chapter 5.4 --- Limitations --- p.136 / Chapter 5.5 --- Implications --- p.141 / Appendices --- p.145 / Chapter A --- Self-administered Questionnaire --- p.145 / Bibliography --- p.151
|
2 |
Characterization of inhibitory activities from Chinese medicinal herbs and in vitro-selected synthetic RNA ligands against HIV-1 protease.January 2000 (has links)
by Lam Tin Lun. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2000. / Includes bibliographical references (leaves 131-151). / Abstracts in English and Chinese. / Acknowledgment --- p.I / Table of content --- p.II / List of Tables --- p.IX / List of Figures --- p.XI / Abbreviation --- p.XIII / Abstract --- p.XIV / 論文摘要 --- p.XVI / Chapter CHAPTER 1 --- INTRODUCTION --- p.1 / Chapter 1.1 --- Acquired immunodeficiency syndrome (AIDS) --- p.1 / Chapter 1.1.1 --- History of AIDS --- p.1 / Chapter 1.1.2 --- Definition of AIDS --- p.2 / Chapter 1.1.3 --- HIV/AIDS Around the World --- p.4 / Chapter 1.1.4 --- HIV/AIDS in Hong Kong --- p.4 / Chapter 1.1.4.1 --- Hong Kong AIDS Update --- p.4 / Chapter 1.1.4.2 --- AIDS Transmission --- p.6 / Chapter 1.1.4.3 --- Main AIDS Complications Occur in Hong Kong --- p.6 / Chapter 1.2 --- Human Immunodeficiency Virus (HIV) --- p.7 / Chapter 1.2.1 --- Classification of HIV --- p.7 / Chapter 1.2.2 --- The Structure of HIV Virion --- p.9 / Chapter 1.2.3 --- The HIV Genome --- p.11 / Chapter 1.2.4 --- The Life Cycle of HIV --- p.12 / Chapter 1.2.4.1 --- Invasion of the Cells --- p.12 / Chapter 1.2.4.2 --- Integration into cell genome --- p.13 / Chapter 1.2.4.3 --- Protease and assembly to the virus --- p.13 / Chapter 1.2.5 --- Three Essential Enzymes for HTV-1 Replication --- p.16 / Chapter 1.2.5.1 --- HIV-1 Reverse Transcriptase (HIV-1 RT) --- p.16 / Chapter 1.2.5.2 --- HIV-1 Integrase (HIV-1 IN) --- p.17 / Chapter 1.2.5.3 --- HIV-1 Protease (HIV-1 PR) --- p.18 / Chapter 1.2.6 --- The Different Stages of HIV Infection --- p.19 / Chapter 1.3 --- AIDS therapy --- p.23 / Chapter 1.3.1 --- Drugs Approved by US Food and Drug Administration (FDA) --- p.23 / Chapter 1.3.2 --- Vaccine --- p.26 / Chapter 1.3.3 --- Chemokine Receptor Inhibitor --- p.27 / Chapter 1.3.4 --- Antisense Oligonucleotides Therpay --- p.28 / Chapter 1.3.5 --- Traditional Chinese Medicine (TCM) --- p.29 / Chapter 1.4 --- Objective of My Project --- p.32 / Chapter CHAPTER 2 --- SCREENING OF TRADITIONAL CHINESE MEDICINAL PLANTS FOR HIV-1 PROTEASE INHIBITION --- p.33 / Chapter 2.1 --- Introduction --- p.33 / Chapter 2.2 --- Materials and Methods --- p.35 / Chapter 2.2.1 --- Materials --- p.35 / Chapter 2.2.2 --- Extraction Methods --- p.36 / Chapter 2.2.2.1 --- Aqueous Extraction --- p.36 / Chapter 2.2.2.2 --- Methanol Extraction --- p.37 / Chapter 2.2.3 --- Preparation of Recombinant HIV-1 Protease --- p.37 / Chapter 2.2.3.1 --- Selection of Appropriate Clone --- p.37 / Chapter 2.2.3.2 --- Large-scale Expression of Recombinant HIV-1 Protease --- p.38 / Chapter 2.2.2.3 --- Purification of Recombinant HIV-1 Protease by DEAE Sepharose CL-6B Chromatography --- p.38 / Chapter 2.2.3.4 --- Purification of Recombinant HIV-1 Protease by Mono-S Cation Chromatography --- p.39 / Chapter 2.2.3.5 --- Refolding of Purified Recombinant HIV-1 Protease --- p.40 / Chapter 2.2.3.6 --- Protein Concentration Determination --- p.41 / Chapter 2.2.3.7 --- Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) --- p.41 / Chapter 2.2.4 --- Characterization of HTV-1 Protease --- p.42 / Chapter 2.2.4.1 --- HIV-1 PR Fluorogenic Assays --- p.42 / Chapter 2.2.4.2 --- HIV-1 PR Assay by Reverse Phase HPLC Separation of Cleavage Products of the Synthetic Peptide Substrate --- p.43 / Chapter 2.3 --- Results --- p.44 / Chapter 2.3.1 --- Functional Analysis of Recombinant HIV-1 PR Activity --- p.44 / Chapter 2.3.2 --- Screening of Crude Extracts for Inhibition of HIV-1 PR Activity --- p.48 / Chapter 2.4 --- Discussion --- p.53 / Chapter CHAPTER 3 --- ISOLATION AND CHARACTERIZATION OF ACTIVE CONSTITUENTS FROM METHANOL EXTRACTS OF WOODWARDIA UNIGEMMATA AGAINST HIV-1 PROTEASE --- p.56 / Chapter 3.1 --- Introduction --- p.56 / Chapter 3.2 --- Materials and Methods --- p.57 / Chapter 3.2.1 --- Materials --- p.57 / Chapter 3.2.2 --- Methods --- p.58 / Chapter 3.2.2.1 --- Methanol Extraction --- p.58 / Chapter 3.2.2.2 --- Removal of Tannins --- p.60 / Chapter 3.2.2.3 --- Glucosidase Digestion --- p.60 / Chapter 3.2.2.4 --- Analytical Thin Layer Chromatographic (TLC) --- p.61 / Chapter 3.2.2.5 --- A cid Hydrolysis --- p.62 / Chapter 3.2.2.6 --- Electrospray Mass Spectrometry --- p.62 / Chapter 3.2.2.7 --- Dose-response Curve --- p.63 / Chapter 3.2.2.8 --- Kinetic Studies --- p.63 / Chapter 3.2.2.9 --- Activity of the HPLC-purified principle (s) on Other Aspartyl Proteases --- p.63 / Chapter 3.3 --- Results --- p.66 / Chapter 3.3.1 --- Purification of Methanol Extracts of Woocdwardia unigemmata --- p.66 / Chapter 3.2.2 --- Removal of Tannins --- p.70 / Chapter 3.2.3 --- Glucosidase Digestion --- p.73 / Chapter 3.2.4 --- Acid Hydrolysis --- p.73 / Chapter 3.2.5 --- Analytical Thin Layer Chromatography --- p.74 / Chapter 3.2.6 --- Electrospray Mass Spectrometry --- p.80 / Chapter 3.2.7 --- Dose-response Inhibition of HIV-1 Protease --- p.80 / Chapter 3.2.8 --- Kinetic Studies --- p.85 / Chapter 3.2.9 --- Effects of HPLC-purified Active Principle on Other Aspartyl Proteases --- p.87 / Chapter 3.3 --- Discussion --- p.89 / Chapter CHATPER 4 --- IDENTIFICATION OF SELECTIVE RNA APTAMERS AGAINST HIV-1 PROTEASE BY SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT (SELEX) --- p.95 / Chapter 4.1 --- Introduction --- p.95 / Chapter 4.2 --- Materials and Methods --- p.101 / Chapter 4.2.1 --- Materials --- p.101 / Chapter 4.2.2 --- Methods --- p.102 / Chapter 4.2.2.1 --- PCR Amplification for the Generation of a Double-Stranded DNA Library --- p.103 / Chapter 4.2.2.2 --- Preparation of RNA Pools --- p.104 / Chapter 4.2.2.3 --- In vitro Selection of RNA Ligands --- p.104 / Chapter 4.2.2.4 --- Reverse Transcription Reaction of Selected RNA --- p.108 / Chapter 4.2.2.5 --- Cloning of the Amplified cDNA pools --- p.108 / Chapter 4.2.2.6 --- Subcloning of the digested DNA product into pBluescript® IIKS (-) --- p.108 / Chapter 4.2.2.8 --- RNA Labeling with Digoxigenin (DIG) --- p.109 / Chapter 4.2.2.9 --- Binding Affinity of RNA Ligands for HIV-1 PR --- p.109 / Chapter 4.2.2.10 --- Competition Binding Reactions --- p.111 / Chapter 4.2.2.11 --- HIV-1 PR Inhibitory Activities of the Selected RNA Ligands --- p.112 / Chapter 4.3 --- Results --- p.113 / Chapter 4.3.1 --- In Vitro Selection of RNA Ligands --- p.113 / Chapter 4.3.2 --- Sequences of RNA Ligands --- p.114 / Chapter 4.3.3 --- Binding Affinity of RNA Ligands --- p.114 / Chapter 4.3.4 --- Inhibitory Activity of RNA Ligands --- p.119 / Chapter 4.4 --- Discussion --- p.122 / Chapter CHAPTER 5 --- GENERAL DISCUSSION --- p.128 / REFERENCES --- p.132
|
3 |
Characterization of HIV related risk behaviors of injecting drug users in Hong Kong.January 2008 (has links)
Li, Huizhen. / "March 2008." / Thesis (M.Phil.)--Chinese University of Hong Kong, 2008. / Includes bibliographical references (leaves 139-150). / Abstracts in English and Chinese. / Abstract --- p.ii / Acknowledgement --- p.vii / Abbreviations --- p.ix / Introduction --- p.1 / Chapter 1.1 --- HIV and AIDS --- p.4 / Chapter 1.1.1 --- HIV Transmission Routes --- p.5 / Chapter 1.1.2 --- HIV Related Risk Behaviors --- p.6 / Chapter 1.2 --- HIV Burden --- p.7 / Chapter 1.2.1 --- HIV Infection in China --- p.7 / Chapter 1.2.2 --- HIV Infection in Hong Kong --- p.9 / Chapter 1.2.3 --- Methadone Treatment in Hong Kong --- p.10 / Chapter 1.3 --- Objectives and Hypothesis --- p.14 / Chapter 1.4 --- Organization of This Thesis --- p.15 / Literature Review --- p.16 / Chapter 2.1 --- Search Methods --- p.18 / Chapter 2.1.1 --- Formulating Review Questions --- p.18 / Chapter 2.1.2 --- Search Strategy --- p.19 / Chapter 2.1.3 --- Inclusion and Exclusion Criteria --- p.21 / Chapter 2.2 --- Assessing the Quality of Studies --- p.22 / Chapter 2.3 --- Search Results --- p.23 / Chapter 2.3.1 --- Descriptive Summary --- p.25 / Chapter 2.3.2 --- Critique of Reviewed Articles --- p.33 / Chapter 2.4 --- Implication on Planning of Current Study --- p.37 / Chapter 2.4.1 --- Summary of Reviewed Articles --- p.37 / Methods for Exploring Predictors of HIV Risk --- p.40 / Chapter 3.1 --- Data Source --- p.42 / Chapter 3.1.1 --- Data Management in Methadone Clinics --- p.42 / Chapter 3.1.2 --- Source of Data --- p.43 / Chapter 3.2 --- Data Transformation --- p.45 / Chapter 3.3 --- Framework for assessing outcome --- p.48 / Chapter 3.3.1 --- Study population in different analyses --- p.48 / Chapter 3.3.2 --- Risk Score --- p.49 / Chapter 3.3.3 --- Independent Variables --- p.50 / Chapter 3.4 --- Generalized Linear Model --- p.52 / Chapter 3.5 --- Logistic Regression Model --- p.54 / Chapter 3.6 --- Multilevel Analyses --- p.55 / Chapter 3.6.1 --- Variables --- p.56 / Chapter 3.6.2 --- Definition of 'Neighborhood' --- p.56 / Chapter 3.6.3 --- Individual Variables --- p.60 / Chapter 3.6.4 --- Framework for Analyses --- p.60 / Chapter 3.7 --- Field Study --- p.63 / Results: Community Variation of HIV Risk --- p.65 / Chapter 4.1 --- Demographic Description --- p.67 / Chapter 4.1.1 --- Age distribution --- p.67 / Chapter 4.1.2 --- Gender Distribution --- p.68 / Chapter 4.1.3 --- Proportion of New Admission --- p.72 / Chapter 4.2 --- Drug Taking Profile --- p.74 / Chapter 4.2.1 --- Heroin Use --- p.74 / Chapter 4.2.2 --- Injecting Heroin Users --- p.77 / Chapter 4.3 --- HIV related risk behaviors --- p.81 / Chapter 4.3.1 --- Injection History --- p.81 / Chapter 4.3.2 --- Risky Injection Practices --- p.87 / Chapter 4.3.3 --- Sexual Behaviors --- p.93 / Chapter 4.4 --- Correlation between Demographics and Risk Score --- p.94 / Chapter 4.4.1 --- General Linear Regression Model Coefficient --- p.94 / Chapter 4.4.2 --- Risk Predictors in Logistic Regressions --- p.95 / Chapter 4.5 --- Neighborhood Effect --- p.100 / Chapter 4.6 --- On-site Observation --- p.103 / Chapter 4.6.1 --- Demographic Variations --- p.103 / Chapter 4.6.2 --- Drug Use Variations --- p.104 / Chapter 4.6.3 --- Social Background --- p.105 / Discussion --- p.111 / Chapter 5.1 --- Neighborhood Effect --- p.113 / Chapter 5.1.1 --- Variation across Communities --- p.113 / Chapter 5.1.2 --- Implication on Social Network of IDUs --- p.115 / Chapter 5.2 --- Decline of Admissions --- p.117 / Chapter 5.2.1 --- Decrease of New Admissions --- p.117 / Chapter 5.2.2 --- Decline of Readmission in 2003 --- p.119 / Chapter 5.3 --- Female IDU Population --- p.121 / Chapter 5.4 --- Limitations --- p.125 / Chapter 5.4.1 --- Importance of Individual Level Variables and Community Level Variables --- p.125 / Chapter 5.4.2 --- Reliability of Self-reported Data --- p.126 / Chapter 5.4.3 --- Duplicates of Readmissions --- p.126 / Chapter 5.4.4 --- Definition of Syringe Reuse --- p.127 / Chapter 5.4.5 --- Choice of Models --- p.129 / Conclusion and Future Directions --- p.131 / Chapter 6.1 --- Summary of Results --- p.133 / Chapter 6.2 --- Implication of results --- p.134 / Chapter 6.3 --- Future Directions --- p.136 / Bibliography --- p.139
|
Page generated in 0.0674 seconds